Effects of umeclidinium/vilanterol (UME/VIL) versus umeclidinium (UME) on exertional dyspnea and respiratory mechanics in moderate COPD
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.pa2192
Abstract: We examined the physiological rationale for using a dual long-acting bronchodilator versus its anticholinergic component as treatment for dyspnea and exercise intolerance in moderate COPD patients. Methods: This randomized, double-blind, crossover study examined UME/VIL 125/25μg… read more here.
Keywords: ume vil; versus; moderate copd; respiratory ... See more keywords